1.67
+0.0556(+3.45%)
Currency In USD
| Previous Close | 1.61 |
| Open | 1.61 |
| Day High | 1.67 |
| Day Low | 1.61 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.21 |
| Volume | 30,501 |
| Average Volume | 102,903 |
| Market Cap | 12.5M |
| PE | -1.13 |
| EPS | -1.47 |
| Moving Average 50 Days | 1.73 |
| Moving Average 200 Days | 1.73 |
| Change | 0.06 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.06 as of June 30, 2025 at a share price of $1.666. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $4,164 as of June 30, 2025 at a share price of $1.666.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
GlobeNewswire Inc.
Jun 18, 2025 1:35 PM GMT
MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleas
BioRestorative Announces Share Repurchase Program
GlobeNewswire Inc.
Jun 17, 2025 1:25 PM GMT
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today an
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
GlobeNewswire Inc.
Jun 13, 2025 11:45 AM GMT
– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and funct